3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform Reykjavik – 3Z, a Reykjavik based drug discovery company is pleased toannounce the closure of a $2 million funding round led by seasoned investorsin pharmaceuticals and medical technology. The just closed funding willaccelerate finalization...